Cancer

Oral cancer detection by dentists is significantly on the rise

After examining data gathered over an 11-year period in a first-of-its-kind provincial study, University of Toronto clinician-scientist Marco Magalhaes has one vital message: dentists in Ontario are detecting more cases of ...

Cancer

FDA approves pembrolizumab plus axitinib for advanced RCC

(HealthDay)—The combination of pembrolizumab and axitinib has been approved as a first-line treatment in advanced renal cell carcinoma (RCC), the U.S. Food and Drug Administration announced Friday.

page 1 from 23